| S-25 |
Application of pharmacogenetic informations to individualized medicine: scientific, clinical and regulatory issues |
| |
S25-1. |
Does a genetic-based approach improve the efficacy and safety of anticoagulation therapy by warfarin ? |
| |
S25-2. |
Tailored strategy for eradication of H. pylori infection based on CYP2C19 genotype approved as the advanced medicine |
| |
S25-3. |
accuracy and management of individual genetic informations |
| |
S25-4. |
Requirements for the clinical application of human genome variation data |
 |
|
|
